Cytovale Inc.

Biotechnology company · San Francisco, California, United States

Cytovale Inc. is a biotechnology company headquartered in San Francisco, California, United States. The US FDA lists 1 medical device site registered to the company, with devices in microbiology. It has received 4 US government small-business research awards (SBIR/STTR) from health agencies, $2.8 million in total, most recently in 2016. It has reported private securities offerings to the US SEC, most recently $16 million sold in a notice filed in 2022.

Profile compiled from public records. Is this your company? Request a correction or update

Cytovale at a glance

Typebiotechnology company
HeadquartersSan Francisco, California, United States
FDA-registered sites1
Employees (per SBIR records)4
SEC CIK1725779

What does Cytovale do?

Medical specialties of its FDA-listed devices

Microbiology

Device types listed with the FDA

Deformability cytometry for sepsis risk assessment

US government research funding

4 SBIR/STTR small-business research awards from US health agencies, $2.8 million in total (2013 to 2016). NIH funding came from the National Heart, Lung, and Blood Institute.

Private fundraising reported to the SEC

3 Form D notices; the most recent reported $16.4 million sold (2022).

Where is Cytovale located?

Headquarters: San Francisco, California, United States

  • South San Francisco, CaliforniaCytovale, Inc. · FDA device site

Frequently asked questions about Cytovale

Where is Cytovale headquartered?

Cytovale Inc. is headquartered in San Francisco, California, United States.

What does Cytovale do?

Cytovale Inc. is a biotechnology company. Its FDA-listed medical devices fall under microbiology.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Sources

Location data: GeoNames (geonames.org), CC BY 4.0.

Last updated 2026-09-23.